Neuropsychological consequences of chronic opioid use: A quantitative review and meta-analysis

Neuroscience and Biobehavioral Reviews

Volumn 36, Issue 9, 2012, Pages 2056-2068

  Baldacchino, A ^a   Balfour, D J K ^a   Passetti, F ^b   Humphris, G ^c   Matthews, K ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Addaction ^*  (United Kingdom)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Meta analysis; Neuropsychology; Opioids; Risk taking; Verbal fluency; Verbal memory

Indexed keywords

BEHAVIOR DISORDER; COGNITIVE DEFECT; DISEASE ASSOCIATION; EFFECT SIZE; HIGH RISK BEHAVIOR; HUMAN; LONG TERM MEMORY; MEMORY DISORDER; MENTAL DISEASE; OBSERVATIONAL STUDY; OPIATE ADDICTION; OUTCOME ASSESSMENT; PERSEVERATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE STUDY; REVIEW; SHORT TERM MEMORY; SPEECH ARTICULATION; SYSTEMATIC REVIEW; VERBAL MEMORY; WORKING MEMORY;

COGNITION; HUMANS; IMPULSIVE BEHAVIOR; MEMORY; OPIOID-RELATED DISORDERS; RISK-TAKING;

EID: 84865602885     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2012.06.006     Document Type: Review

References (94)

1. Amir T., Bahei T. Effect of substance-abuse on visuographic function. Perceptual and Motor Skills 1994, 78:235-241.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1952, APA, Washington, DC. 3rd ed.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1987, APA, Washington, DC. 3rd ed. text revision.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, APA, Washington, DC. 4th ed.
5. Annelli V., Ollila J., Matikainen E., Rosenberg P., Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. The Lancet 1995, 346:667-670.
6. Baumeister R.F., Scher S.J. Self-defeating behavior patterns among normal individuals: review and analysis of common self-destructive tendencies. Psychological Bulletin 1988, 104:3-22.
7. Bechara A., Martin E.M. Impaired decision making related to working memory deficits in individuals with substance addictions. Neuropsychology 2004, 18:152-162.
8. Bickel W.K., Marsch L.A. Toward a behavioral economic understanding of drug dependence: delay discounting processes. Addiction 2001, 96:73-86.
9. Brand M., Roth-Bauer M., Driessen M., Markowitsch H.J. Executive functions and risky decision-making in patients with opiate dependence. Drug and Alcohol Dependence 2008, 7:64-72.
10. Borenstein M., Hedges L.V., Higgins J.P.T., Rothstein H.R. Introduction to Meta-Analysis 2009, Wiley, Chichester.
11. Byas-Smith M.G., Chapman S.L., Reed B., Cotsonis G. The effect of opioids on driving and psychomotor performance in patients with chronic pain. Clinical Journal of Pain 2005, 21(4):345-352.
12. Camerer C., Weber M. Recent developments in modelling preferences: uncertainty and ambiguity. Journal of Risk and Uncertainty 1992, 5:325-370.
13. Chou R., Clarke E., Helfand M. Comparative efficiency and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. Journal of Pain and Symptom Management 2003, 26(5):1026-1048.
14. Clark L., Robbins T.W., Ersche K.D., Sahakian B.J. Reflection impulsivity in chronic and former substance users. Biological Psychiatry 2006, 60:512-522.
15. Cohen J. A power primer. Psychological Bulletin 1992, 112(1):155-159.
16. Cohen J. Statistical Power Analysis for the Behavioural Sciences 1988, Lawrence Erlbaum Associates, New Jersey, Hillsdale. 2nd ed.
17. Comprehensive Meta Analysis Version 2 2011, Bio Stat Englewood, New Jersey, US, Accessed from: http://www.Meta-Analysis.com.
18. Cooper H., Hodges L.V. The Handbook of Research Synthesis 1984, Russel Sage Foundation, New York.
19. Cooper M.L., Wood P.K., Orcutt H.K., Albino A. Personality and the predisposition to engage in risky or problem behaviors during adolescence. Journal of Personality and Social Psychology 2003, 84(2):390-410.
20. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K., Pena Y., Murphy E.R., Shah Y., Probst K., Abakumova I., Aigbirhio F.I., Richards H.K., Hong Y., Baron J.C., Everitt B.J., Robbins T.W. Nucleus accumbens D 2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
21. Damakis G.J. Meta-analysis in neuropsychology: basic approaches, findings, and applications. Clinical Neuropsychology 2006, 20:10-26.
22. Darke S., Sims J., McDonald S., Wickes W. Cognitive impairment among methadone maintenance patients. Addiction 2000, 95(5):687-695.
23. Davis P.E., Liddiard H., McMillan T.M. Neuropsychological deficits and opiate abuse. Drug and Alcohol Dependence 2002, 67:105-108.
24. Dickman S.J. Functional and dysfunctional impulsivity-personality and cognitive correlates. Journal of Personality and Social Psychology 1990, 58:95-102.
25. Eisch A.J., Barrot M., Schad C.A., Self D.W., Nestler E.J. Opiates inhibit neurogenesis in the adult rat hippocampus. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:7579-7584.
26. EPHPP: Effective Public Health Practice Project: Quality Assessment Checklist. McMaster University.
27. Ernst M., Paulus M.P. Neurobiology of decision making: a selective review from a neurocognitive and clinical perspective. Biological Psychiatry 2005, 58:597-604.
28. Ersche K., Roiser J.P., Clark L., London M., Robbins T.W., Sahakian B.J. Punishment induces risky decision making in methadone maintained opiate users but not in heroin users or healthy volunteers. Neuropsychopharmacology 2005, 30:2115-2124.
29. Ersche K.D., Clark L., London M., Robbins T.W., Sahakian B.J. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 2006, 31:1036-1047.
30. Ersche K.D., Sahakian B.J. The neuropsychology of amphetamine and opiate dependence: implications for treatment. Neuropsychology Review 2007, 17:317-336.
31. Evenden J.L. Varieties of impulsivity. Psychopharmacology 1999, 146:348-361.
32. Fan X-L., Zhang J-S., Zhang X-Q., Ma L. Chronic morphine treatment and withdrawal induce up regulation of c Jun N-Terminal Kinase gene expression in rat brain. Neuroscience 2003, 122:997-1002.
33. Fernandez-Serrano M.J., Perez-Garcia M., Verdejo-Garcia A. What are the specific vs. generalised effects of drugs of abuse on neuropsychological performance?. Neuroscience and Biobehavioral Reviews 2011, 35(3):377-406.
34. Fishbein D.H., Krupitsky E., Flannery B.A., Langevin D.J., Bobashev G., Verbitskaya E., Augustine C.B., Bolla K.I., Zvartau E., Schech B., Egorova V., Bushara N., Tsoy M. Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug and Alcohol Dependence 2007, 90:25-38.
35. Gaertner J., Radbruch L., Giesecke T., Gerbershagen H., Petzke F., Ostgathe C., Elsner F., Sabatowski R. Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients. Acta Anaesthesiologica Scandinavica 2006, 50(6):664-672.
36. Gouzoulis-Mayfrank E., Daumann J., Tuchtenhagen F., Pelz S., Becker S., Kunert H.J., Fimm B., Sass H. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). Journal of Neurology and Neurosurgery and Psychiatry 2000, 68:719-725.
37. Grattan L., Eslinger P. Higher cognition and social behaviour. Changes in cognitive flexibility and empathy after cerebral lesions. Neuropsychology 1989, 3:175-185.
38. Gruber S.A., Tzilos G.K., Silveri M.M., Pollack M., Renshaw P.F., Kaufman M.J., Yurgelun-Todd D.A. Methadone maintenance improves cognitive performance in a test of decision-making by opiate dependent tobacco smokers. Drug and Alcohol Dependence 2006, 73:79-86.
39. Guerra D., Sol A., Cami J., Tobena A. Neuropsychological performance in opiate addicts after rapid detoxification. Drug and Alcohol Dependence 1987, 20:261-270.
40. Hedges L.V., Orkin I. Statistical Methods for Meta-analysis 1985, Academic Press, San Diego, CA.
41. Hedges L.V., Verea J.L. Fixed-and random effects models in meta-analysis. Psychological Methods 1998, 3:486-504.
42. Higgins J.P.T., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analysis. British Medical Journal 2003, 327:557-560.
43. 2 index. Psychological Methods 2006, 11:193-206.
44. Hunter J.E., Schmidt F.L. Methods of Meta-analysis 1990, Sage Publications, Newbury Park, CA.
45. Ioannidis J.P.A. Why most published research findings are false. PLoS Medicine 2005, 2(8):e124. 10.1371/journal.pmed.0020124.
46. Kelley D., Welch R., McKnelley W. Methadone maintenance: an assessment of potential fluctuations in behaviour between doses. The International Journal of Addictions 1978, 13(7):1061-1068.
47. Kirby K.N., Petry N.M., Bickel W.K. Heroin addicts have higher discount rates for delayed rewards than non-drug using controls. Journal of Experimental Psychology 1999, 128:78-87.
48. Knoch D., Fehr E. Resisting the power of temptations: the right prefrontal cortex and self-control. Annals of New York Academy of Science 2007, 1104:123-134.
49. Lezak M.D., Howieson D.B., Lorain D.W. Neuropsychological Assessment 2004, Oxford University Press, New York. 4th ed.
50. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gøtzsche P.C., Ioannidis J.P.A., Clarke M., Devereaux P.J., Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals of Internal Medicine 2009, 151(4):65-94.
51. Mensch B.S., Kandel D.B. Underreporting of substance use in a national longitudinal youth cohort: individual and interviewer effects. Public Opinion Quarterly 1988, 52:100-124.
52. Miller L. Neuropsychological assessment of substance abusers: review and recommendations. Journal of Substance Abuse Treatment 1985, 2:5-17.
53. Mintzer M.Z., Copersino M.L., Stitzer M.L. Opioid abuse and cognitive performance. Drug and Alcohol Dependence 2005, 78:225-230.
54. Ornstein T.J., Iddon J.L., Baldacchino A.M., Sahakian B.J., London M., Everitt B.J., Robbins T.W. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 2000, 23(2):113-126.
55. Orwin R.G. A Fail Safe N for effect size. Journal of Educational Statistics 1983, 8:157-159.
56. Owen A.M. Cognitive planning in humans: neuropsychological, neuroanatomical and neuropharmacological perspectives. Progress in Neurobiology 1997, 53:431-450.
57. Passetti F., Clark L., Mehta M.A., Joyce E., King M. Neuropsychological predictors of clinical outcome in opiate addiction. Drug and Alcohol Dependence 2008, 94:82-91.
58. Pirastu M., Fais R., Messina M., Bini V., Spiga S., Falconieri D., Diana M. Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. Drug and Alcohol Dependence 2006, 83:163-168.
59. Prosser J., Cohen L.J., Steinfeld M., Eisenberg D., London E.D., Galynker I.I. Neuropsychological functioning in opiate dependent subjects receiving and following methadone maintenance treatment. Drug and Alcohol Dependence 2006, 84:240-247.
60. Quinhana S.M., Minami T. Guidelines for meta-analyses of counselling psychology research. Counselling Psychologist 2006, 34:839-877.
61. Reynolds B. A review of delay-discounting research with humans: relations to drug use and gambling. Behavioural Pharmacology 2006, 17(8):651-667.
62. Robbins T.W., Cardinal R.N., Di Ciano P., Halligan P.W., Hellemans K.G.C., Lee J.L.C., Everitt B.J. Drug Futures 2025? 2005, Department of Trade and Industry, UK Government, London.
63. Rosenthal R. Writing meta-analytic reviews. Psychological Bulletin 1995, 118-192.
64. Rotherham-Fuller E., Shoptaw S., Berman S.M., London E.D. Impaired performance in a test of decision-making by opiate-dependent tobacco smokers. Drug and Alcohol Dependence 2004, 73:79-86.
65. Rounsaville J.B., Jones C., Novelly R.A., Kleber A. Neuropsychological functioning in opiate addicts. The Journal of Nervous and Mental Disease 1982, 170(4):209-216.
66. Sabatowski R., Schwaren S., Rettig K., Herberg K.W., Kasper S.M., Radbruch L. Driving ability under long term treatment with transdermal fentanyl. Journal of Pain and Symptom Management 2003, 25(1):38-47.
67. Sainani K.L. The problem of multiple testing. American Academy of Physical Medicine and Rehabilitation 2009, 1:1098-1103.
68. Schindler S-D., Ortner, Peternell R., Eder A., Opgenoorth H., FischerG.E. Maintenance therapy with synthetic opioids and driving aptitude. European Addiction Research 2004, 10:80-87.
69. Scottish Government The Road to Recovery. A New Approach to Tackling Scotland's Drug Problem 2008, Scottish Government, Edinburgh.
70. Selby M.J., Azrin R.L. Neuropsychological functioning in drug users. Drug and Alcohol Dependence 1998, 50(1):39-45.
71. Sjogren P., Olsen A.K., Thomsen A.B., Dalberg J.A. Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status. Pain 2000, 86:237-245.
72. Sjogren P., Christup L.L., Peterson M.A., Hojsted J. Neuropsychological assessment of chronic non-malignant pain patients treated in a multidisciplinary pain centre. European Journal of Pain 2005, 9:453-462.
73. Soyka M., Hock H., Kagerer S., Lehnert R., Limmer C., Kuefner H. Less impairment on one portion of a driving relevant psychomotor battery in buprenorphine-maintained than in methadone maintained patients. Journal of Clinical Psychopharmacology 2005, 25(5):490-493.
74. Soyka M., Lieb M., Kagerer S., Zingg C., Koller G., Lehnert P., Limmer P., Kuefner H., Henning-Fast K. Cognitive functioning during methadone and buprenorphine treatment. Journal of Clinical Psychopharmacology 2008, 28(6):699-703.
75. Specka M., Finkbeiner Th., Lodemann E., Leifert K., Kluwig J., Gastpar M. Cognitive-motor performance of methadone maintained patients. European Addiction Research 2000, 6:8-19.
76. Spitzer R.L., Robins E. Research diagnostic criteria: rationale and reliability. Archives of General Psychiatry 1978, 35(6):773-782.
77. Strauss E., Sherman E.M.S., Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms and Commentary 2006, Oxford University Press, New York.
78. Stevens A., Ines P., Jurgen S. Implicit learning executive function and hedonic activity in chronic polydrug abusers, currently abstinent poly-drug abusers and controls. Addiction 2007, 102:937-946.
79. Strang J., Gurling H. Computerized tomography and neuropsychological assessment in long-term high dose heroin addicts. British Journal of Addictions 1989, 84:1019-1911.
80. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., Moher D., Becker B.J., Sipe T.A., Thacker S.B. Meta-analysis of observational studies in epidemiology: a proposal for reporting to systematically review the literature (MOOSE Guidelines). Journal of the American Medical Association 2008, 283:2008-2012.
81. Sutton A.J., Duval S.J., Tweedie R.L., Abrams K.R., Jones D.R. Empirical assessment of effect of publication bias on meta-analyses. British Medical Journal 2000, 320:1574-1577.
82. Tassain N.V., Fletcher A.D., Brasseur L., Degieux P., Chauvin M., Bouhassira D. Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain 2003, 104:389-400.
83. Verdejo-Garcia A., Lopez-Torrecillas F., Gimenez C.O., Perez-Garcia M. Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. Neuropsychology Review 2004, 14(1):1-41.
84. Verdejo-Garcia A.J., Perez-Garcia M. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology 2007, 190:517-530.
85. Verdejo-Garcia A.J., Perales J.C., Perez-Garcia M. Cognitive impulsivity in cocaine and heroin polysubstance abusers. Addictive Behaviours 2007, 32:950-966.
86. Whiteside S.P., Lynam D.R. The five factor model and impulsivity: using a structural model of personality to understand impulsivity. Personality and Individual Differences 2001, 30:669-689.
87. WHO The ICD-9 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research 1977, World Health Organization, Geneva.
88. WHO The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research 1993, World Health Organization, Geneva.
89. Wolf F.M. Meta-Analysis. Quantitative Methods for Research Synthesis 1986, Sage Publications, Newbury, CA.
90. Wood M.M., Ashby M.A., Somogyi A.A., Fleming B.G. Neuropsychological and pharmacokinetic assessment of hospice inpatients receiving morphine. Journal of Pain and Symptom Management 1998, 16(2):112-120.
91. Zacny J.P. A review of the effects of opioids on psychomotor and cognitive functioning in humans. Experimental and Clinical Psychopharmacology 1995, 3(4):432-466.
92. Zakazanis K.K., Leach L., Kaplan E. Neuropsychological Differential Diagnosis 1999, Suets and Zeitlinger, Lisse, Netherlands.
93. Zakzanis K.K. Statistics to tell the truth, the whole truth and nothing but the truth: formulae, illustrative numerical examples, and heuristic interpretation of effect size analyses for neuropsychological researchers. Archives of Clinical Neuropsychology 2001, 16:653-667.
94. Zakzanis K.K., Cambell Z., Jovanovski D. The neuropsychology of ecstasy (MDMA) use: a quantitative review. Human Psychopharmcology and Clinical Experimentation 2007, 22:427-435.